FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 12:47:51 26/06/2024 am IST | ||
| 0.37 EUR | 0.00% |
|
| Current month | +8.82% | ||
| 1 month | +5.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 25/24/25 | 0.37 | 0.00% |
| 24/24/24 | 0.37 | +2.78% |
| 21/24/21 | 0.36 | +5.88% |
| 20/24/20 | 0.34 | +3.03% |
| 19/24/19 | 0.33 | 0.00% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 12:47 am IST
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Morgan Stanley |
| WKN | MD3KJ9 |
| ISIN | DE000MD3KJ99 |
| Date issued | 11/04/2022 |
| Strike | 31.68 $ |
| Maturity | Unlimited |
| Parity | 26.06 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.16 € |
|---|---|
| Lowest since issue | 0.32 € |
| Spread | 0.01 € |
| Spread % | 2.56% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.19
USD
Average target price
53.19
USD
Spread / Average Target
+26.08%
- Stock Market
- Certificates
- Certificat
